Quick Takeaways
- Redmile Group, LLC filed SCHEDULE 13G/A for Immunome, Inc. Common Stock, $0.0001 par value per share (IMNM).
- Disclosed ownership: 5.2%.
- Date of event: 31 Dec 2025.
Redmile Group, LLC - 31 Dec 2025 SCHEDULE 13G/A Report for Immunome, Inc. Common Stock, $0.0001 par value per share (IMNM)
- Filing Manager
- Redmile Group, LLC
- Reporting Manager
- Redmile Group, LLC
- Symbol
- IMNM
- Shares outstanding
- 109,968,942 shares
- Disclosed Ownership
- 5,718,385 shares
- Ownership
- 5.2%
- Form type
- SCHEDULE 13G/A
- Filing time
- 17 Feb 2026, 16:15:47 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 15 May 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Redmile Group, LLC disclosed 5.2% ownership in Immunome, Inc. Common Stock, $0.0001 par value per share (IMNM) on 31 Dec 2025."
What Changed
- Previous schedule filing date: 15 May 2025.
- Current filing was accepted on 17 Feb 2026, 16:15.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Redmile Group, LLC | 5.2% | 5,718,385 | 0 | 5,718,385 | /s/ Jeremy C. Green | Managing Member | |
| Jeremy C. Green | 5.2% | 5,718,385 | 0 | 5,718,385 | /s/ Jeremy C. Green | Jeremy C. Green |